| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO | President &CEO +3 more
4 companies
Kaye Edward M. Md is a Director at Sarepta Therapeutics, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $5.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2020 | STOK Stoke Therapeutics, Inc. | CEO | Sell | 25,000 | $60.00 | $1,500,000.00 | -82.8% | |
| Nov 27, 2020 | STOK Stoke Therapeutics, Inc. | CEO | Sell | 12,152 | $50.00 | $607,600.00 | -32.7% | |
| Nov 25, 2020 | STOK Stoke Therapeutics, Inc. | CEO | Sell | 12,848 | $50.00 | $642,400.00 | -25.7% | |
| Oct 5, 2020 | CYTK Cytokinetics Inc | Director | Sale+OE | 20,000 | $30.00 | $600,000.00 | -100% | |
| Jul 20, 2017 | SRPT Sarepta Therapeutics, Inc. | Director | Sell | 10,000 | $41.00 | $410,000.00 | -16.0% | |
| Sep 22, 2016 | SRPT Sarepta Therapeutics, Inc. | President, CEO &CMO | Sale+OE | 40,179 | $60.00 | $2,410,740.00 | -34.3% | |
| Sep 19, 2016 | SRPT Sarepta Therapeutics, Inc. | President, CEO &CMO | Sale+OE | 24,352 | $50.00 | $1,217,600.00 | -9.5% | |
| Sep 14, 2016 | SRPT Sarepta Therapeutics, Inc. | SVP Interim CEO &CMO | Sell | 24,557 | $30.00 | $736,710.00 | -24.2% | |
| Feb 27, 2015 | SRPT Sarepta Therapeutics, Inc. | SVP &Chief Medical Officer | Buy | 800 | $11.82 | $9,452.00 | +156.6% |